ISA104
/ ISA Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 14, 2023
HEB-PEP: Evaluation of the Novel Therapeutic Hepatitis B Virus Synthetic Long Peptide Vaccination ISA104
(clinicaltrials.gov)
- P1/2 | N=24 | Recruiting | Sponsor: Erasmus Medical Center | Not yet recruiting ➔ Recruiting | Initiation date: May 2023 ➔ Aug 2023
Enrollment open • Trial initiation date • Hepatitis B • Hepatology • Infectious Disease • Inflammation
May 03, 2023
HEB-PEP: Evaluation of the Novel Therapeutic Hepatitis B Virus Synthetic Long Peptide Vaccination ISA104
(clinicaltrials.gov)
- P1/2 | N=24 | Not yet recruiting | Sponsor: Erasmus Medical Center
New P1/2 trial • Hepatitis B • Hepatology • Infectious Disease • Inflammation
1 to 2
Of
2
Go to page
1